← All companies
RAPH
Raphael Pharmaceutical Inc.
$1.40
+0.00 0.00%
Key statistics
from XBRL data in SEC filingsMarket cap
$28.2M
Revenue (TTM)
—
Net income (TTM)
-$1.08M
EPS (TTM)
$0.06
P/E ratio
23.3
Dividend yield
—
Free cash flow
-$212K
Cash
$1.00K
Total assets
$3.00K
Gross margin
—
52-week range
$0.22 – $1.40
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Director or officer change
Jul 17, 2026
10-Q
Quarter ended 2026-03-31
May 14, 2026
10-K
Fiscal year ended 2025-12-31
Mar 31, 2026
8-K
Director or officer change
Mar 24, 2026
10-Q
Quarter ended 2025-09-30
Nov 13, 2025
10-Q
Quarter ended 2025-06-30
Aug 13, 2025
8-K
Director or officer change
Aug 11, 2025
8-K
Other events
Aug 11, 2025
10-Q
Quarter ended 2025-03-31
May 15, 2025
10-K
Fiscal year ended 2024-12-31
Mar 31, 2025
8-K
Director or officer change
Jan 14, 2025
8-K
Other events
Dec 30, 2024
10-Q
Quarter ended 2024-09-30
Nov 14, 2024
8-K
Changed accountants
Sep 11, 2024
10-Q
Quarter ended 2024-06-30
Aug 12, 2024
8-K
Amended charter or bylaws
Jun 26, 2024
10-Q
Quarter ended 2024-03-31
May 15, 2024
8-K
Other events
May 2, 2024
10-K
Fiscal year ended 2023-12-31
Mar 28, 2024
10-Q
Quarter ended 2023-09-30
Nov 14, 2023
10-Q
Quarter ended 2023-06-30
Aug 9, 2023
10-K/A
Fiscal year ended 2022-12-31
May 25, 2023
10-Q
Quarter ended 2023-03-31
May 15, 2023
8-K
Other events
Mar 28, 2023
10-K
Fiscal year ended 2022-12-31
Mar 24, 2023
8-K/A
Director or officer change
Jan 26, 2023
10-Q
Quarter ended 2022-09-30
Nov 14, 2022
8-K
Other events
Oct 24, 2022
10-Q
Quarter ended 2022-06-30
Aug 12, 2022
8-K
Changed accountants; Director or officer change
Jul 7, 2022
10-Q
Quarter ended 2022-03-31
May 16, 2022
10-K
Fiscal year ended 2021-12-31
Mar 30, 2022
10-Q
Quarter ended 2021-09-30
Nov 16, 2021
8-K
Changed accountants
May 29, 2013
10-Q
Quarter ended 2010-09-30
Nov 12, 2010
8-K
Unregistered sale of equity; Director or officer change
Oct 5, 2010
8-K
Director or officer change
Aug 25, 2010
10-Q
Quarter ended 2010-06-30
Aug 6, 2010
10-Q
Quarter ended 2010-03-31
May 14, 2010
10-K
Fiscal year ended 2009-12-31
Apr 19, 2010